Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Curr Opin HIV AIDS. 2023 Sep 11;18(6):349–356. doi: 10.1097/COH.0000000000000818

Figure 3.

Figure 3.

Historical placebo-arm HIV incidence for HIV prevention efficacy trials in men who have sex with men (MSM), 2004 to 2014 spanning Australia, Brazil, Canada, Dominican Republic, Ecuador, England, France, Haiti, Jamaica, Peru, Puerto Rico, South Africa, Thailand, United States, and a counterfactual placebo HIV incidence estimate based on the historical incidence data. The placebo-arm HIV incidence for HVTN 704/HPTN 085 (2016–2020; United States, Peru, Switzerland, Brazil) is shown for comparison.

HPTN 039 (ClinicalTrials.gov #NCT00076232)

HVTN 502 (ClinicalTrials.gov #NCT00865566)

HVTN 704 (ClinicalTrials.gov #NCT02716675)iPrEx (ClinicalTrials.gov #NCT00458393)

Ipergay (ClinicalTrials.gov #NCT01473472)

PROUD (ClinicalTrials.gov #NCT02065986)